(2-(Dimethoxymethyl)-1-heptenyl)benzene
Common Name: |
(2-(Dimethoxymethyl)-1-heptenyl)benzene |
IUPAC Name: |
[(E)-2-(dimethoxymethyl)hept-1-enyl]benzene |
Molecular Formula: |
C16H24O2 |
SMILES: |
CCCCCC(=CC1=CC=CC=C1)C(OC)OC |
Inchi: |
1S/C16H24O2/c1-4-5-7-12-15(16(17-2)18-3)13-14-10-8-6-9-11-14/h6,8-11,13,16H,4-5,7,12H2,1-3H3/b15-13+ |
Inchi Key: |
QCHZKUPVENJLAW-FYWRMAATSA-N |
Cas No: |
91-87-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
248.36 |
Mass (g/mol) |
248.178 |
Molar Refractivity |
77.16 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
8 |
Rings |
1 |
TPSA |
18.46 |
Hetero Atoms |
2 |
Heavy Atoms |
18 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
300.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.00016 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.50 |
LogP |
4.269 |
iLOGP |
3.52 |
XLOGP3 |
4.88 |
WLOGP |
4.16 |
MLOGP |
3.49 |
ESOL Log S |
-4.17 |
ESOL Solubility (mg/ml) |
0.017 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-5.00 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-4.80 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.35 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.129 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.905 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |